EPCAM and neoplasm: Moreover, a recent study demonstrated that the combination of anti-Tim3 mAb, T-cell redirecting bispecific antibody MT110 (EpCAM x CD3), and IL2 could further enhance the anti-tumor effects of the transfused Vγ2Vδ2 T cells in tumor-bearing nude mice (13).